Leonidas Chelis

488 total citations
22 papers, 396 citations indexed

About

Leonidas Chelis is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Leonidas Chelis has authored 22 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Leonidas Chelis's work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Lung Cancer Research Studies (4 papers) and Cancer-related gene regulation (4 papers). Leonidas Chelis is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Lung Cancer Research Studies (4 papers) and Cancer-related gene regulation (4 papers). Leonidas Chelis collaborates with scholars based in Greece, United States and Saudi Arabia. Leonidas Chelis's co-authors include Stylianos Kakolyris, Nikolaos Xenidis, Kyriakos Amarantidis, Anastasios J. Karayiannakis, V. Danielides, Maria Riga, Helen Bolanaki, Prodromos Michailidis, Εkaterini Chatzaki and Dimitrios Matthaios and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Leonidas Chelis

22 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leonidas Chelis Greece 11 121 115 111 104 69 22 396
Claudia Gedlicka Austria 12 157 1.3× 244 2.1× 91 0.8× 48 0.5× 18 0.3× 16 383
Marius Petrulionis Lithuania 6 122 1.0× 60 0.5× 23 0.2× 57 0.5× 10 0.1× 13 227
Gui Cheng China 11 73 0.6× 60 0.5× 92 0.8× 20 0.2× 54 0.8× 14 316
Sujuan Fei China 13 138 1.1× 162 1.4× 74 0.7× 121 1.2× 12 0.2× 25 338
Hiroki Izumi Japan 14 175 1.4× 251 2.2× 179 1.6× 55 0.5× 3 0.0× 68 528
Peter Zentis Germany 9 186 1.5× 135 1.2× 41 0.4× 34 0.3× 4 0.1× 12 446
Elena Kupert United States 11 299 2.5× 59 0.5× 142 1.3× 49 0.5× 19 0.3× 16 416
Claire Calmel France 11 144 1.2× 81 0.7× 53 0.5× 36 0.3× 5 0.1× 20 318
Judd W. Moul United States 10 193 1.6× 90 0.8× 232 2.1× 61 0.6× 52 0.8× 13 476

Countries citing papers authored by Leonidas Chelis

Since Specialization
Citations

This map shows the geographic impact of Leonidas Chelis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonidas Chelis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonidas Chelis more than expected).

Fields of papers citing papers by Leonidas Chelis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leonidas Chelis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonidas Chelis. The network helps show where Leonidas Chelis may publish in the future.

Co-authorship network of co-authors of Leonidas Chelis

This figure shows the co-authorship network connecting the top 25 collaborators of Leonidas Chelis. A scholar is included among the top collaborators of Leonidas Chelis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leonidas Chelis. Leonidas Chelis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mahalingam, Devalingam, Leonidas Chelis, Sunyoung S. Lee, et al.. (2021). Detection of Hepatocellular Carcinoma in a High-Risk Population by a Mass Spectrometry-Based Test. Cancers. 13(13). 3109–3109. 5 indexed citations
2.
3.
Matthaios, Dimitrios, Ioanna Balgkouranidou, Anastasios J. Karayiannakis, et al.. (2016). Methylation status of the APC and RASSF1A promoter in cell-free circulating DNA and its prognostic role in patients with colorectal cancer. Oncology Letters. 12(1). 748–756. 50 indexed citations
4.
Riga, Maria, et al.. (2016). Systematic review on T3 laryngeal squamous cell carcinoma; still far from a consensus on the optimal organ preserving treatment. European Journal of Surgical Oncology. 43(1). 20–31. 20 indexed citations
5.
Balgkouranidou, Ioanna, Dimitrios Matthaios, Anastasios J. Karayiannakis, et al.. (2015). Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 778. 46–51. 65 indexed citations
6.
Mahalingam, Devalingam, W. Kenneth Washburn, Glenn A. Halff, et al.. (2015). Abstract 1567: A mass spectrometry based serum test for the detection of hepatocellular carcinoma (HCC) in high risk patients. Cancer Research. 75(15_Supplement). 1567–1567. 2 indexed citations
7.
Riga, Maria, et al.. (2015). Hyposmia: an underestimated and frequent adverse effect of chemotherapy. Supportive Care in Cancer. 23(10). 3053–3058. 15 indexed citations
8.
Kentepozidis, Nikolaos, Αthanasios Kotsakis, Aspasia Soultati, et al.. (2013). Docetaxel plus cisplatin and bevacizumab for untreated patients with advanced/metastatic non-squamous non-small-cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research Group. Cancer Chemotherapy and Pharmacology. 71(3). 605–612. 11 indexed citations
9.
Chelis, Leonidas, Grigorios Trypsianis, Nikolaos Xenidis, et al.. (2013). Circulating biomarkers of sorafenib efficacy in advanced HCC.. Journal of Clinical Oncology. 31(4_suppl). 302–302. 2 indexed citations
10.
Chelis, Leonidas, et al.. (2012). Reversible Posterior Leukoencephalopathy Syndrome Induced by Pazopanib. BMC Cancer. 12(1). 489–489. 33 indexed citations
11.
Hountis, Panagiotis, et al.. (2012). Prognostic significance of different immunohistochemical S100A2 protein expression patterns in patients with operable nonsmall cell lung carcinoma. OncoTargets and Therapy. 5. 363–363. 6 indexed citations
12.
Chelis, Leonidas, Savas Deftereos, Nikolaos Xenidis, et al.. (2012). Bevacizumab plus temsirolimus as second-line treatment for advanced hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. 30(15_suppl). e14567–e14567. 5 indexed citations
13.
Xenidis, Nikolaos, Leonidas Chelis, Kyriakos Amarantidis, et al.. (2011). Docetaxel plus gemcitabine in combination with capecitabine as treatment for inoperable pancreatic cancer: a phase II study. Cancer Chemotherapy and Pharmacology. 69(2). 477–484. 11 indexed citations
14.
Riga, Maria, Leonidas Chelis, Stylianos Kakolyris, et al.. (2011). Transtympanic Injections of N-acetylcysteine for the Prevention of Cisplatin-induced Ototoxicity. American Journal of Clinical Oncology. 36(1). 1–6. 83 indexed citations
15.
Amarantidis, Kyriakos, Nikolaos Xenidis, Leonidas Chelis, et al.. (2011). Docetaxel plus Oxaliplatin in Combination with Capecitabine as First-Line Treatment for Advanced Gastric Cancer. Oncology. 80(5-6). 359–365. 18 indexed citations
16.
Karayiannakis, Anastasios J., Stylianos Kakolyris, Alexandra Giatromanolaki, et al.. (2011). Hepatoid Adenocarcinoma of the Gallbladder. Journal of Gastrointestinal Cancer. 43(S1). 139–144. 11 indexed citations
17.
Karayiannakis, Anastasios J., Stylianos Kakolyris, Georgios Kouklakis, et al.. (2011). Synchronous Breast and Rectal Cancers in a Man. SHILAP Revista de lepidopterología. 4(2). 281–286. 9 indexed citations
18.
19.
Xenidis, Nikolaos, Αthanasios Kotsakis, A. Kalykaki, et al.. (2009). Etoposide plus cisplatin followed by concurrent chemo-radiotherapy and irinotecan plus cisplatin for patients with limited-stage small cell lung cancer: A multicenter phase II study. Lung Cancer. 68(3). 450–454. 5 indexed citations
20.
Amarantidis, Kyriakos, Nikolaos Xenidis, Leonidas Chelis, et al.. (2009). A dose escalation study of docetaxel plus capecitabine in combination with oxaliplatin in patients with advanced solid tumors. Acta Oncologica. 49(2). 245–251. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudia Gedlicka Breakdown of academic impact, for papers by Marius Petrulionis Breakdown of academic impact, for papers by Gui Cheng Breakdown of academic impact, for papers by Sujuan Fei Breakdown of academic impact, for papers by Hiroki Izumi Breakdown of academic impact, for papers by Peter Zentis Breakdown of academic impact, for papers by Elena Kupert Breakdown of academic impact, for papers by Claire Calmel Breakdown of academic impact, for papers by Judd W. Moul
Rankless by CCL
2026